This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 1CTCL
- 1clonotypic heterogeneity
- 1cutaneous T-cell lymphoma
- 1genomic heterogeneity
- 1immunogenicity
- 1immunotherapy
-
Fall 2021
Background Mycosis fungoides (MF) is the most common cutaneous T-cell lymphoma (CTCL). Early stage disease, limited to skin patches & plaques, is indolent. However, progression to tumour stage disease marks a significant drop in survival to less than 4 years. Treatments for advanced disease are...
-
Spring 2020
Cutaneous T-cell lymphoma (CTCL) is heterogeneous form of T-cell lymphoma of which, Mycosis fungoides (MF) is the most common entity. In early stages MF presents on skin as a scaly plaques that in advanced stages develop into tumors and may disseminate to other sites such as lymph node and...